New psychosis after marijuana use revealed autoimmune encephalitis
Bilateral pulmonary embolism in anti-NMDA receptor encephalitis presenting as acute psychosis.
AI Summary
This case report examined a previously healthy 26-year-old man who developed acute psychosis 3 days after first-time marijuana use, following substantial emotional stress. He was initially diagnosed with brief psychotic disorder, but the later appearance of catatonia and fever prompted further investigation. Anti-NMDA receptor antibodies in the cerebrospinal fluid and blood confirmed anti-NMDA receptor encephalitis, an autoimmune condition that can resemble a primary psychiatric illness.
The patient’s hospitalization was complicated by bilateral pulmonary emboli and drug-induced liver injury. He showed marked improvement after treatment with intravenous immunoglobulin and high-dose corticosteroids, while evaluation for malignancy was negative. The report emphasizes that young people with new-onset psychosis—especially when neurological or systemic symptoms develop—may require early cerebrospinal-fluid testing. This abstract-based summary cannot establish that marijuana caused the illness or determine whether it contributed to the timing or severity of the presentation; it describes a single case and does not provide comparative or population-level evidence.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Mental Health research papers you might find interesting.
Brain blood-flow reductions in acute anorexia follow a cortical hierarchy
CBD showed limited adaptive-functioning differences versus placebo in boys…
Resilience linked to depression outcomes and THC positivity
Explore More Research
Stay informed about the latest cannabis science.